Clinical Trials Logo

Coeliac Disease clinical trials

View clinical trials related to Coeliac Disease.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06001177 Recruiting - Celiac Disease Clinical Trials

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

SynCeD
Start date: December 13, 2023
Phase: Phase 2
Study type: Interventional

The study goal is to evaluate the efficacy, safety, and tolerability of KAN-101 in participants with Celiac Disease (CeD)

NCT ID: NCT05786183 Recruiting - Coeliac Disease Clinical Trials

Rapid Technique for the Detection of Intestinal Anti-transglutaminase Antibodies

Start date: February 15, 2020
Phase:
Study type: Observational

Intestinal Celiac Disease (CD)-antibodies have been described as the best marker to reveal progression toward villous atrophy and could become the diagnostic marker to make prompt diagnosis in the wide clinical spectrum of CD reducing the delay in diagnosis and treatment. The introduction of either anti-endomysial antibodies (EMA) assay or rapid anti-Transglutaminase 2 (TG2) test on supernatant of mechanically lysed biopsy samples in the clinical practice would improve the diagnosis of CD, especially in clinically challenging scenarios. The availability of an accurate test for identifying intestinal CD-antibodies that do not need the culture of intestinal biopsy is less expensive, less time consuming and easier to perform would facilitate the implementation of such technology outside research laboratories, and enable the diagnosis of CD at the end of Gastrointestinal Endoscopy (GIE).

NCT ID: NCT05530070 Recruiting - Coeliac Disease Clinical Trials

Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies

ARCTIC
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This investigation examines the most important cardiovascular risk factors (e.g., metabolic parameters, body composition) and their changes in coeliac disease. The series of studies allow to assess body composition and cardiovascular risk-related metabolic parameters of newly diagnosed and treated coeliac patients in their complexity and to test if they change during therapy. The interventional part of the investigation aims to answer the question if a dietary intervention mitigates the unfavorable effects of unbalanced diet.